Four versus five chemotherapy courses in patients with low risk acute myeloid leukemia: A Children’s Oncology Group report.

Kelly Getz; Todd A. Alonzo; Lillian Sung; Soheil Meshinchi; Robert B. Gerbing; Susana C. Raimondi; Betsy Hirsch; Samir B. Kahwash; John Choi; E. Anders Kolb

doi:10.1200/jco.2017.35.15_suppl.10515

Four versus five chemotherapy courses in patients with low risk acute myeloid leukemia: A Children’s Oncology Group report.

Identifier:nobleid.org/w1/20260515/CE2BC636

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CE2BC636.svg?ark=w1%2F20260515%2FCE2BC636)](https://nobleid.org/work/w1/20260515/CE2BC636)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Four versus five chemotherapy courses in patients with low risk acute myeloid leukemia: A Children’s Oncology Group report.

Identifier:nobleid.org/w1/20260515/CE2BC636

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CE2BC636.svg?ark=w1%2F20260515%2FCE2BC636)](https://nobleid.org/work/w1/20260515/CE2BC636)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work